Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Wood

Showing results (11-20 of 211) with videos related to

Pageof 22
Sort By:
Peptides|January 1, 1988
The significance of multiple CNS opioid receptor types: a review of critical considerations relating to technical details and anatomy in the study of central opioid actionsP L Wood
Neuropeptides|February 1, 1985
In vivo evaluation of mu, delta and kappa opioid receptor agonists on spinal 5-HT metabolism in the ratP L Wood
Neuropeptides|February 1, 1985
N-tetrahydrofurfuryl benzomorphans: comparison of a kappa and an agonist/antagonist analgesicP L Wood
Life Sciences|January 1, 1995
The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?P L Wood
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Opioid receptor affinities of kappa agonists, agonist/antagonists and antagonists in vitro and in vivoP L Wood
Expert Opinion on Investigational Drugs|July 5, 2005
NMDA antagonists for stroke and head trauma: current statusP L Wood
Idrugs : the Investigational Drugs Journal|May 10, 2008
Small molecule inducers of neurotrophic functionP L Wood
Peptides|September 1, 1983
Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differencesP L Wood
Idrugs : the Investigational Drugs Journal|July 29, 2005
The real value of HTC and HTS: increased diversity of molecular approaches to enter clinical evaluation in pharmaceutical R&DP L Wood
Canadian Journal of Physiology and Pharmacology|March 1, 1986
Pharmacological evaluation of GABAergic and glutamatergic inputs to the nucleus basalis--cortical and the septal-hippocampal cholinergic projectionsP L Wood
Pageof 22

Showing results (11-20 of 211) with videos related to

Sort By:
Pageof 22
Peptides|January 1, 1988
The significance of multiple CNS opioid receptor types: a review of critical considerations relating to technical details and anatomy in the study of central opioid actionsP L Wood
Neuropeptides|February 1, 1985
In vivo evaluation of mu, delta and kappa opioid receptor agonists on spinal 5-HT metabolism in the ratP L Wood
Neuropeptides|February 1, 1985
N-tetrahydrofurfuryl benzomorphans: comparison of a kappa and an agonist/antagonist analgesicP L Wood
Life Sciences|January 1, 1995
The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?P L Wood
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
Opioid receptor affinities of kappa agonists, agonist/antagonists and antagonists in vitro and in vivoP L Wood
Expert Opinion on Investigational Drugs|July 5, 2005
NMDA antagonists for stroke and head trauma: current statusP L Wood
Idrugs : the Investigational Drugs Journal|May 10, 2008
Small molecule inducers of neurotrophic functionP L Wood
Peptides|September 1, 1983
Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differencesP L Wood
Idrugs : the Investigational Drugs Journal|July 29, 2005
The real value of HTC and HTS: increased diversity of molecular approaches to enter clinical evaluation in pharmaceutical R&DP L Wood
Canadian Journal of Physiology and Pharmacology|March 1, 1986
Pharmacological evaluation of GABAergic and glutamatergic inputs to the nucleus basalis--cortical and the septal-hippocampal cholinergic projectionsP L Wood
Pageof 22